150. The Evolution Of The Neurohormonal Hypothesis With Dr. Milton Packer: Part 5 The Ejected Fraction Of A Destroyed Heart
CardioNerds\xa0(Amit Goyal,\xa0Daniel Ambinder) and Dr. Mark Belkin, (CardioNerds Correspondent) and Dr. Shirlene Obuobi (CardioNerds Ambassador) from University of Chicago are honored to bring to you the Dr. Milton Packer perspective on the evolution of the neurohormonal hypothesis as part of The CardioNerds Heart Success Series.\n\n\n\nIn part 5, Dr. Packer shares his thoughts on the term\xa0\u201cguideline directed medical therapy,\u201d guidelines in general, and the challenges of using the ejection fraction to measure systolic function.\n\n\n\nCheck out the\xa0CardioNerds\xa0Heart Failure Success Series Page\xa0for more heart success episodes and content!\n\n\n\nThis is a non CME episode. Disclosures: Milton Packer reports receiving consulting fees from\xa0Abbvie, Actavis,\xa0Amgen, Amarin,\xa0AstraZeneca,\xa0Boehringer Ingelheim,\xa0Bristol Myers Squibb, Casana, CSL Behring,\xa0Cytokinetics,\xa0Johnson & Johnson Health Care Systems Inc., Eli Lilly and Company,\xa0Moderna, Novartis, ParatusRx, Pfizer, Relypsa, Salamandra, Synthetic Biologics,\xa0Teva Pharmaceuticals USA Inc.\xa0and Theravance Biopharma Inc.\n\n\n\n\n\n\n\n\n\nCardioNerds\xa0Heart Failure Success Series PageCardioNerds Episode PageCardioNerds AcademyCardionerds Healy Honor Roll\n\n\n\n\n\nCardioNerds Journal ClubSubscribe to The Heartbeat Newsletter!Check out CardioNerds SWAG!Become a CardioNerds Patron!\n\n\n\n\n\nThis CardioNerds\xa0Heart Failure Success Series was created in memory of Dr. David Taylor. We thank our partners at the Heart Failure Society of America\xa0which is a multidisciplinary organization working to improve and expand heart failure care through collaboration, education, research, innovation, and advocacy. Its members include physicians, scientists, nurses, nurse practitioners, and pharmacists. Learn more at\xa0hfsa.org.